Prostate Cancer: Later Stage Treatment
Prostate Cancer: Later Stage Treatment
Treatment for advanced prostate disease has improved dramatically over the last 10 years and continues to improve. In this series, SurvivorNet doctors help compare the pros and cons of each treatment.
- There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
- Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
- Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).
Later Stage Treatment: New Treatment Developments
- There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
- Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
- Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).
Later Stage Treatment: Hormone Therapy
Later Stage Treatment: Radiation Therapy
New Options When Other Medications Are Not Working
George Crawford, a native New Yorker, has been through a lot in his 81 years. He lived through World War II, he was in the Navy during the Cuban Missile Crisis; he's done a lot of living and he has a lot of stories to tell. But receiving his prostate cancer diagnosis still came as a big shock. "When my doctor told me t... Read More
Later Stage Treatment: Are Clinical Trials an Option?
What is the Immunotherapy Vaccine?
You may have heard about Provenge (also known as Sipuleucel-T), which is the only immunotherapy vaccine currently FDA-approved for the treatment of late-stage prostate cancer. Like other immunotherapy drugs, it uses a patient's own immune system to attack the cancer cells. The vaccine is usually given to men who have e... Read More